New study aims to predict liver injury outcomes in thousands of patients
NCT ID NCT05060289
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 3000 people in China who have drug-induced liver injury (DILI) to understand what factors affect their recovery. Researchers will collect blood samples and health data to create a model that predicts serious outcomes like liver failure or death. The goal is to improve how doctors manage DILI and identify patients who need closer monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a tool that helps doctors better predict who will recover or need a liver transplant after drug-induced liver injury.
- What could go wrong
- This is an observational study, not a treatment trial. The model may not work for all patients or be ready for use for many years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INDUCED LIVER INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing 302 Hospital
RECRUITINGBeijing, Beijing Municipality, 100166, China
-
Beijing Ditan Hospital
ACTIVE_NOT_RECRUITINGBeijing, 100102, China
-
Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, 100050, China
-
Beijing You 'an Hospital, Capital Medical University
RECRUITINGBeijing, 100069, China
-
Hebei CNPC Central Hospital
ACTIVE_NOT_RECRUITINGHebei, 050011, China
-
Jiaozuo People's Hospital
RECRUITINGJiaozuo, 454002, China
-
Peking University Third Hospital
ACTIVE_NOT_RECRUITINGBeijing, 100191, China
-
Qinghai People's Hospital
RECRUITINGQinghai, 810007, China
-
Qinzhou First People's Hospital
ACTIVE_NOT_RECRUITINGGuangxi, 535009, China
-
The Affiliated Hospital of Qingdao University
RECRUITINGQingdao, 266003, China
-
The Second Affiliated Hospital of Dalian Medical University
RECRUITINGDalian, 116023, China
-
The Second Hospital of Lanzhou University
RECRUITINGLanzhou, 730046, China
-
Yuncheng Central Hospital
RECRUITINGYuncheng, 044099, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may solve tricky liver diagnosis puzzle
- New study aims to uncover the impact of itching in liver injury patients
- Massive study tracks hidden liver dangers of common drugs and herbal remedies
- New study collects data and samples to unlock mysteries of Drug-Induced liver damage
- Blood cancer patients may get liver protection from common drug
- Milk thistle extract may help repair Medication-Damaged livers